Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies

Veterinary Microbiology

Volumn 133, Issue 3, 2009, Pages 239-251

  Seki, Cristina ^a   Robiolo, Blanca ^a   Periolo, Osvaldo ^a   Iglesias, Marcela ^a   D'Antuono, Alejandra ^a   Maradei, Eduardo ^b   Barros, Virginia ^b   La Torre, José ^a   Mattion, Nora ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b Servicio Nacional de Sanidad y Calidad Agroalimentaria Argentina   (Argentina)

Author keywords

Antigenic profiles; FMDV; Monoclonal antibodies; Trapping ELISA; Vaccine control; Viral integrity

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; MONOCLONAL ANTIBODY;

ANTIGENIC VARIATION; AQUEOUS SOLUTION; ARTICLE; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; SENSITIVITY AND SPECIFICITY; SUCROSE DENSITY GRADIENT CENTRIFUGATION; VACCINE PRODUCTION; VIRION; VIRUS PARTICLE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, VIRAL; ARGENTINA; CATTLE; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; QUALITY CONTROL; VIRAL VACCINES;

FOOT-AND-MOUTH DISEASE VIRUS;

EID: 57549086475     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2008.07.011     Document Type: Article

References (37)

1. Auge de Mello P., Olascoaga R.C., Costa Giomi M.P., Alonso Fernandez A., Scodeller E.A., La Torre J.L., and Bergmann I.E. RNA fingerprinting of South American prototype aphtovirus strains. Vaccine 4 (1986) 105-110
2. Bergmann I., Auge de Mello P., and Domingo E. Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle. J. Virol. 62 (1988) 2041-2049
3. Capstick P.B., Telling R.C., Chapman W.G., and Stewart D.L. Growth of a cloned strain of hamster cells in suspended cultures and their susceptibility to the virus of foot-and-mouth disease. Nature 195 (1962) 1163-1164
4. Chen S.P., Cheng I.C., Huang T.S., Tu W.J., Jong M.H., and Yang P.C. Antibody responses against foot-and-mouth disease virus (O Taiwan strain) after vaccination of swine with various vaccines. In: Done S., Thomson J., and Varley M. (Eds). Proceedings of 15th IPVS Congress, vol. II. Birmingham, England (1998) 175
5. Costa Giomi M.P., Durini L., Bergmann I., Mazzuca O., Aued de Rau M.E., Fernandez G., Parisi J.M., and La Torre J.L. Estudios antigénicos y bioquímicos combinados de cepas prototipo y de campo de los virus de la fiebre aftosa en la República Argentina. Bull. O.I. Epizooties 1 (1982) 263-272
6. Crowther J.R. The use of monoclonal antibodies in the molecular typing of animal viruses. Rev. Sci. Tech. Off. Int. Epiz. 12 (1993) 369-383
7. Crowther J.R., Reckziegel P.O., and Prado J.A. Quantification of whole virus particles (146S) of foot-and-mouth disease virus in the presence of virus subunits (12S), using monoclonal antibodies in a sandwich ELISA. Vaccine 13 (1995) 1064-1075
8. Davie J.A. Complement fixation technique for the quantitative measurement of antigenic differences between strains of the virus of foot-and-mouth disease. J. Hygiene 62 (1964) 401-411
9. Diez J., Mateu M.G., and Domingo E. Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay. J. Gen. Virol. 70 (1989) 3281-3289
10. Doel T.R., and Collen T. Qualitative assessment of 146S particles of foot-and-mouth disease virus in preparations destined for vaccines. J. Biol. Stand. 10 2 (1982) 69-81
11. Doel T.R., and Collen T. The detection and inhibition of proteolytic enzyme activity in concentrated preparations of inactivates foot-and-mouth disease virus. J. Biol. Stand. 11 1 (1983) 35-46
12. Doel T.R., and David D.J. The stability and potency of vaccines prepared from inactivated foot-and-mouth disease virus concentrates. J. Biol. Stand. 12 3 (1984) 247-255
13. Domingo E., Escarmís C., Baranowski E., Ruiz-Jarabo C.M., Carrillo E., Núñez J.I., and Sobrino F. Evolution of foot-and-mouth disease virus. Virus Res. 91 1 (2003) 47-63
14. Earley E.M., and Rener J.C. Hybridoma technology I: murine monoclonal antibodies. J. Tissue Cult Methods 9 (1985) 129-187
15. Frenkel H.S. Research on foot and mouth disease. II. The cultivation of virus on a practical scale in explantations of bovine tongue epithelium. Am. J. Vet. Res. 12 (1951) 187-190
16. García-Barreno B., Sanz A., Nogal M.L., Viñuela E., and Enjuanes L. Monoclonal antibodies of African Swine Fever virus: antigenic differences among field virus isolates and viruses passaged in cell culture. J. Virol. 58 (1986) 385-392
17. Gebauer F., de la Torre J.C., Gomes I., Mateu M.G., Barahona H., Tiraboschi B., Bergmann I., Auge de Mello P., and Domingo E. Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle. J. Virol. 62 (1988) 2041-2049
18. Giraudo A.T., Sagedahl A., Bergmann I.E., La Torre J.L., and Scodeller E.A. Isolation and characterization of recombinants between attenuated and virulent aphthovirus strains. J. Virol. 61 (1987) 419-425
19. Goris N., Maradei E., D'Aloia R., Fondevila N., Mattion N., Perez A., Smitsaart E., Nauwynck H.J., La Torre J., Palma E., and De Clercq K. Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the "Protection against Podal Generalisation" test. Vaccine 26 (2008) 3432-3437
20. Grubman M.J., and Morgen D.O. Antigenic comparison of foot-and-mouth disease virus serotypes with monoclonal antibodies. Virus Res. 6 (1986) 33-43
21. Grubman M.J., and Baxt B. Foot-and-mouth disease. Clin. Microbiol. Rev. 17 2 (2004) 465-493
22. Hamblin C., Barnett I.T.R., and Crowther J.R. A new enzyme linked immunosorbent assay (ELISA) for the detection of antibodies against FMDV. I. Development of a method for ELISA. J. Immunol. Methods 93 (1986) 115-121
23. Kitching R.P., Rendle R., and Ferris N.P. Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus. Vaccine 6 (1988) 403-408
24. König G., Blanco C., Knowles N.J., Palma E.L., Maradei E., and Piccone M.E. Phylogenetic analysis of foot-and-mouth disease virus isolated in Argentina. Virus Genes 23 (2001) 175-181
25. König G.A., Palma E.L., Maradei E., and Piccone M.E. Molecular epidemiology of foot-and-mouth disease virus types A and O isolated in Argentina during the 2000-2002 epizootic. Vet. Microbiol. 124 (2007) 1-15
26. La Torre J.L., Underwood B.O., Lebendiker M., Gorman B.M., and Brown F. Application of RNAse T1 one and two dimensional analyses to the rapid identification of foot-and-mouth diseases viruses. Infect. Immun. 102 (1982) 190-193
27. Mahapatra M., Aggarwal N., Cox S., Statham R.J., Knowles N.J., Barnett P.V., and Paton D.J. Evaluation of a monoclonal antibody-based approach for the selection of foot-and-mouth disease (FMD) vaccine strains. Vet. Microbiol. 126 (2008) 40-50
28. Mattion N., König G., Seki C., Smitsaart E., Maradei E., Robiolo B., Duffy S., Leon E., Piccone M., Sadir A., Biottini R., Cosentino B., Falczuk A., Maresca R., Periolo O., Bellinzoni R., Espinoza A., La Torre J., and Palma E. Reintroduction of foot-and-mouth disease in Argentina: characterization of the isolates and development of tools for the control and eradication of the disease. Vaccine 22 (2004) 4149-4162
29. Mc Cullough K.C., Crowther J.R., Carpenter W.C., Brocchi E., Capucci L., Desimone F., Xie Q., and Mc Cahon D. Epitopes on foot-and-mouth disease virus particles. I. Topology. Virology 157 (1987) 516-525
30. Periolo O.H., Seki C., Grigera P.R., Robiolo B., Fernandez G., Maradei E.D., Aloia R., and La Torre J.L. Large-scale use of liquid-phase blocking sandwich ELISA for the evaluation of protective immunity against aphthovirus in cattle vaccinated with oil-adjuvanted vaccines in Argentina. Vaccine 11 (1993) 754-760
31. Rweyemamu M.M., Booth J.C., Head M., and Pay T.W.F. Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains. J. Hyg. Camb. 81 (1978) 107-123
32. Robiolo B., Grigera P.R., Periolo O.H., Seki C., Bianchi T., Maradei E., and La Torre J.L. Assessment of foot and mouth disease vaccine potency by liquid-phase blocking ELISA: a proposal for an alternative to the challenge procedure in Argentina. Vaccine 13 (1995) 1346-1352
33. Robiolo B., Seki C., Fondevilla N., Grigera P., Scodeller E., Periolo O., La Torre J., and Mattion N. Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests. Vaccine 24 (2006) 997-1008
34. Samuel A.R., Knowles N.J., Samuel G.D., and Crowther J.R. Evaluation of trapping ELISA for differentiation of foot-and-mouth disease virus strains using monoclonal antibodies. Biologicals 19 (1991) 299-310
35. Thomas A.A.M., Woortmeijer R.J., Puijk W., and Barteling S.J. Antigenic sites on foot-and-mouth disease virus Type A10. J. Virol. 62 (1988) 2782-2789
36. Van Maanen C., and Terpstra C. Quantification of intact 146 foot-and-mouth disease antigen for vaccine production by a double antibody sandwich ELISA using monoclonal antibodies. Biologicals 18 (1990) 315-319
37. Vásquez C., Denoya C.D., La Torre J.L., and Palma E.L. Structure of foot-and-mouth disease virus capsid. Virology 97 (1979) 195-200